This session is conducted through video webcasts and will take place in the Eastern time zone. Provided below is the current schedule for the featured presentation. The company’s presentations will be delivered by its executive management team.
CytoDyn Inc. (OTCQB: CYDY) is a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, and is holding its Investment Community Webcast
- Nader Pourhassan, Ph.D., President and Chief Executive Officer
- Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development
- Nitya Ray, Ph.D., Chief Operating Officer and Chief Technology Officer
- Christopher Recknor, M.D., Senior Executive VP of Clinical Operations
CytoDyn will present for 30 minutes, and 60 minutes will be dedicated to live questions and answers.
The Emerging Growth Conference focus and coverage includes a wide range of growth sectors and timely market themes, including, augmented reality, artificial intelligence, scientific, medical instruments and therapeutics, biotechnologies, cannabis, food & beverage, energy and more.
Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally.
The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with the offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.
Thank you for your interest in our conference, and we look forward to your participation in future conferences.